Feedback / Questions
CV6-168 - CV6 Therap
https://www.globenewswire.com/news-release/2024/08/15/2930675/0/en/CV6-Therapeutics-Announces-Initiation-of-Patient-Dosing-in-Phase-1a-Clinical-Trial-Evaluating-the-Investigational-First-In-Class-Specific-dUTPase-Inhibitor-CV6-168.html
Aug 15, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next